Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
Announcement of General Shareholders’ Meeting |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
10 Apr 2023 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the first quarter of 2023
|
Download |
|
21 Feb 2023 |
Annual Corporate Governance Report |
ROVI releases the 2022 Annual Corporate Governance Report
|
Download |
|
21 Feb 2023 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
16 Feb 2023 |
On business and financial situation |
The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
